Opsidio, LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis (NCT06101823) | Opsidio, LLC | 2023-10-25 |
Track Opsidio, LLC automatically
Every clearance here is in the API, with alerts when new ones post.